Evidence-based Complementary And Alternative Medicine SCIE

国际简称：EVID-BASED COMPL ALT 参考译名：循证补充和替代医学

主要研究方向：医学-全科医学与补充医学预警期刊审稿周期：约2.2月

《循证补充和替代医学》(Evidence-based Complementary And Alternative Medicine)是一本由Hindawi Publishing Corporation出版的以医学-全科医学与补充医学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊。

4区中科院分区
Q3 JCR分区
0 年发文量
开放是否OA
72 H-index
2004 创刊年份
Quarterly 出版周期
English 出版语言

Evidence-Based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine.

The journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities, particularly traditional Asian healing systems. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences. The journal does not consider articles on homeopathy.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Evidence-based Complementary And Alternative Medicine期刊信息

ISSN：1741-427X
出版语言：English
是否OA：开放
E-ISSN：1741-4288
出版地区：ENGLAND
是否预警：是
出版商：Hindawi Publishing Corporation
出版周期：Quarterly
创刊时间：2004
开源占比：0.987
Gold OA文章占比：98.70%
OA被引用占比：1
出版国人文章占比：0.51
出版撤稿占比：0.0018...
研究类文章占比：83.06%

Evidence-based Complementary And Alternative Medicine CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

3.5

0.469

0.802

学科类别	分区	排名	百分位
大类：Medicine 小类：Complementary and Alternative Medicine	Q2	32 / 97	67%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Evidence-based Complementary And Alternative Medicine中科院评价数据

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	4区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	4区

Evidence-based Complementary And Alternative Medicine JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位

Evidence-based Complementary And Alternative Medicine历年数据统计

影响因子

中科院分区

Evidence-based Complementary And Alternative Medicine中国学者发文选摘

1、Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics
Author: Zhang, Rui; Lu, Zhe; Xu, Yachen; Peng, Qian; Xiao, Man; Sang, Shenggang

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5625222
2、Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition
Author: Tang, Ling; Yu, Xiao; Zou, Lu; Li, Shaobin; Cheng, Yanqi; Wu, Yuqin; Xing, Lianjun; Fang, Hong

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5642713
3、Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma
Author: Jia, Wenqing; Xu, Chengling; Zhao, Tong; Fan, Qiuyang; Qiao, Bo; Wu, Yueying; Yuan, Jiali; Chen, Jing

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1130893
4、Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease
Author: Chen, Yulian; Song, Xiaodan; Luo, Yunxia; Li, Guandong; Luo, Yueming; Wang, Ziyan; He, Riming; Lu, Jiandong; Xiong, Guoliang; Cheng, Hong; Li, Huilin; Yang, Shudong

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9208017
5、beta-Sitosterol Suppresses LPS-Induced Cytokine Production in Human Umbilical Vein Endothelial Cells via MAPKs and NF-kappa B Signaling Pathway
Author: Bi, Yiming; Liang, Hongfeng; Han, Xin; Li, Kongzheng; Zhang, Wei; Lai, Yigui; Wang, Qiang; Jiang, Xuefeng; Zhao, Xiaoshan; Fan, Huijie

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9241090
6、Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation
Author: Shou, Di-Wen; Li, Yi-Rong; Xu, Xiu-Juan; Dai, Mu-Hua; Zhang, Wei; Yang, Xue; Tu, Yue-Xing

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/8759766
7、Effects of a Macroporous Resin Extract of Dendrobium officinale Leaves in Rats with Hyperuricemia Induced by Anthropomorphic Unhealthy Lifestyle
Author: Li, Lin-Zi; Wang, Xi-Ming; Feng, Xiao-Jie; Liu, Kun; Li, Bo; Zhu, Li-Jie; Xu, Wan-Feng; Zheng, Xiang; Dong, Ying-Jie; He, Xing-Lishang; Guan, Hao-Ru; Ding, Yan-Yan; Wu, Han-Song; Zhou, Chuan-Jie; Ye, Sen-Yu; Zhang, Bei-Bei; Lv, Gui-Yuan; Chen, Su-Hong

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9990843
8、Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer
Author: Wu, Hongyan; Zhang, Lihu; Wang, Chuntao; Li, Fang; Qi, Liang; Xiao, Linxia; Zhang, Mingguang; Zhang, Hu; Zhang, Guozhe; Qin, Yiyu

Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1416841